Screening for Prostate Cancer Starting at Age 50-54. A Population-based Cohort Study

BACKGROUND: Current prostate cancer screening guidelines conflict with respect to the age at which to initiate screening. OBJECTIVE: To evaluate the effect of prostate-specific antigen (PSA) screening, versus zero screening, starting at age 50-54, on prostate cancer mortality. DESIGN, SETTING, AND P...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Urol
Autori principali: Carlsson, Sigrid, Assel, Melissa, Ulmert, David, Gerdtsson, Axel, Hugosson, Jonas, Vickers, Andrew, Lilja, Hans
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061609/
https://ncbi.nlm.nih.gov/pubmed/27084245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2016.03.026
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi